JuLib | Articles & more

1

O-(2-[18F]fluoroethyl]-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas

Pauleit, D.
2005

Brain, 128 (2005) S. 678 - 687

2

Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy

Floeth, F.
2005

Journal of neurosurgery, 102 (2005) S. 318 - 327

3

Journal Article

FET-PET in peripheral tumors: first clinical results

Pauleit, D.
2004

Journal of nuclear medicine, 45 (2004) S. 345P

4

Journal Article

PET with O-(2-[F-18]Fluorethyl)-L-tyrosine (FET) in peripheral tumors (poster presentation)

Pauleit, D.
2004

European journal of nuclear medicine and molecular imaging, 31 (2004) S. s340

5

Journal Article

Comparison of O-(2-18F-fluoroethyl)-L-tyrosine PET and 3-123I-iodo-a-methyl-L-tyrosine SPECT in brain tumors

Pauleit, D.
2004

Journal of nuclear medicine, 45 (2004) S. 374 - 381

6

Conference Presentation

Does the disruption of the blood-brain barrier indicated by contrast enhancement in MRI influence the uptake of FET in gliomas?

Pauleit, D.
2003

7

Conference Presentation

FET PET and IMT SPECT in brain tumors: A comparative study

Pauleit, D.
2003

8

Journal Article

Gleiche Aussagekraft von FET-PET und IMT-SPECT bei Hirntumoren? Eine vergleichende Studie

Pauleit, D.
2003

Nuklearmedizin, 42 (2003) S. A29

9

Poster

Comparison of FET PET and IMT SPECT in patients with brain tumors

Pauleit, D.
2003

10

Poster

Influence of blood-brain barrier disruption on FET uptake in cerebral gliomas

Pauleit, D.
2003

11

Journal Article

Whole-body distribution and dosimetry of O-(2-[18F]fluoroethyl)-L-tyrosine

Pauleit, D.
2003

European Journal of Nuclear Medicine and Molecular Imaging, 30 (2003) S. 519 - 524

12

Conference Presentation

Gleiche Aussagekraft von FET-PET und IMT-SPECT bei Hirntumoren? Eine vergleichende Studie

Pauleit, D.
2003

Narrow Search Results